de Kroon AIPM - Search Results

1

In Vivo Assessment of Thermosensitive Liposomes for the Treatment of Port Wine Stains by Antifibrinolytic Site-Specific Pharmaco-Laser Therapy.

Li M, van Raath MI, Khakpour S, Seçilir A, Sliggers BC, Huang X, Ding B, Storm G, van der Hulst RR, de Kroon AIPM, Heger M. Li M, et al. Among authors: de kroon aipm. Pharmaceutics. 2020 Jun 25;12(6):591. doi: 10.3390/pharmaceutics12060591. Pharmaceutics. 2020. PMID: 32630457 Free PMC article.

2

On the interaction of fluorophore-encapsulating PEGylated lecithin liposomes with hamster and human platelets.

Heger M, Salles II, van Vuure W, Hamelers IH, de Kroon AI, Deckmyn H, Beek JF. Heger M, et al. Microvasc Res. 2009 Jun;78(1):57-66. doi: 10.1016/j.mvr.2009.02.006. Epub 2009 Mar 9. Microvasc Res. 2009. PMID: 19281828

3

Development and in vitro proof-of-concept of interstitially targeted zinc- phthalocyanine liposomes for photodynamic therapy.

Broekgaarden M, de Kroon AI, Gulik TM, Heger M. Broekgaarden M, et al. Curr Med Chem. 2014;21(3):377-91. doi: 10.2174/09298673113209990211. Curr Med Chem. 2014. PMID: 23931271

4

Tranexamic Acid-Encapsulating Thermosensitive Liposomes for Site-Specific Pharmaco-Laser Therapy of Port Wine Stains.

van Raath MI, Weijer R, Nguyen GH, Choi B, de Kroon AI, Heger M. van Raath MI, et al. J Biomed Nanotechnol. 2016 Aug;12(8):1617-40. doi: 10.1166/jbn.2016.2277. J Biomed Nanotechnol. 2016. PMID: 29342342 Free PMC article.

5

Platelets and PEGylated lecithin liposomes: when stealth is allegedly picked up on the radar (and eaten).

Heger M, Salles II, de Kroon AI, Deckmyn H. Heger M, et al. Microvasc Res. 2009 Jun;78(1):1-3. doi: 10.1016/j.mvr.2009.03.003. Epub 2009 Mar 20. Microvasc Res. 2009. PMID: 19306888 No abstract available.

6

Ligation strategies for targeting liposomal nanocarriers.

Marqués-Gallego P, de Kroon AI. Marqués-Gallego P, et al. Biomed Res Int. 2014;2014:129458. doi: 10.1155/2014/129458. Epub 2014 Jul 14. Biomed Res Int. 2014. PMID: 25126543 Free PMC article. Review.

7

Impaired cisplatin influx in an A2780 mutant cell line: evidence for a putative, cis-configuration-specific, platinum influx transporter.

Helleman J, Burger H, Hamelers IH, Boersma AW, de Kroon AI, Stoter G, Nooter K. Helleman J, et al. Cancer Biol Ther. 2006 Aug;5(8):943-9. doi: 10.4161/cbt.5.8.2876. Epub 2006 Aug 2. Cancer Biol Ther. 2006. PMID: 16775422 Free article.

8

Carboplatin nanocapsules: a highly cytotoxic, phospholipid-based formulation of carboplatin.

Hamelers IH, van Loenen E, Staffhorst RW, de Kruijff B, de Kroon AI. Hamelers IH, et al. Mol Cancer Ther. 2006 Aug;5(8):2007-12. doi: 10.1158/1535-7163.MCT-06-0089. Mol Cancer Ther. 2006. PMID: 16928821

9

Nanocapsules: a novel lipid formulation platform for platinum-based anti-cancer drugs.

Hamelers IH, de Kroon AI. Hamelers IH, et al. J Liposome Res. 2007;17(3-4):183-9. doi: 10.1080/08982100701530290. J Liposome Res. 2007. PMID: 18027238

10

Antitumor activity and biodistribution of cisplatin nanocapsules in nude mice bearing human ovarian carcinoma xenografts.

Staffhorst RW, van der Born K, Erkelens CA, Hamelers IH, Peters GJ, Boven E, de Kroon AI. Staffhorst RW, et al. Anticancer Drugs. 2008 Aug;19(7):721-7. doi: 10.1097/CAD.0b013e328304355f. Anticancer Drugs. 2008. PMID: 18594214

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

85 results

Search Page

Filters